Short term complications and risk factors of unilateral biportal endoscopic cervical spine surgery in patients with cervical radiculopathy and myelopathy: a single center retrospective study - Takeaways - MDSpire

Short term complications and risk factors of unilateral biportal endoscopic cervical spine surgery in patients with cervical radiculopathy and myelopathy: a single center retrospective study

  • By

  • Chengyue Zhu

  • Xinning Mao

  • Zhongshu Shan

  • Donghao Du

  • Jiaming Liang

  • Junfeng Shen

  • Hao Pan

  • Wei Zhang

  • Fangcai Li

  • June 17, 2026

  • 0 min

Share

  • 1

    The overall complication rate following unilateral biportal endoscopic cervical spine surgery was 12.1% in the studied cohort.

  • 2

    Complications were more frequent in patients with cervical myelopathy (20.5%) compared to those with cervical radiculopathy (7.4%).

  • 3

    Independent risk factors for complications included age ≥65 years, presence of comorbidities, and undergoing laminectomy.

  • 4

    The learning curve analysis indicated a significantly higher complication rate in the initial 20 cases compared to subsequent cases.

  • 5

    UBE cervical spine surgery is safe for cervical radiculopathy patients, but carries higher risks for myelopathy patients, necessitating careful surgical planning.

Original Source(s)

Short term complications and risk factors of unilateral biportal endoscopic cervical spine surgery in patients with cervical radiculopathy and myelopathy: a single center retrospective study

  • by Chengyue Zhu, Xinning Mao, Zhongshu Shan, Donghao Du, Jiaming Liang, Junfeng Shen, Hao Pan, Wei Zhang, Fangcai Li

  • June 17, 2026

Related Content

Intraoperative MEP and EMG during the wake-up phase as adjuncts to the wake-up test in severe spinal deformity surgery

Trial Exclusions May Skew RA Drug Comparisons

Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.

Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence